Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received ...
Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility own ...
Accomplished pharmaceutical executive brings extensive business development, licensing and finance experience. Seres is implementing a focused corporate strategy to advance live b ...
An archived replay of the webcast will be available on the Tenaya website for approximately 30 days following the conference. About Tenaya Therapeutics Tenaya Therapeutics is a clinical-stage ...
Format: Fireside Chat and 1x1 Investor Meetings Date/Time: Monday, March 9, 2026, from 3:40 – 4:10 pm ET The presentation will be webcast live and archived in the Investor Relations section of ...
Konik Capital Partners LLC, a division of T.R. Winston & Company, is acting as the sole book-running manager for the offering. MAIA intends to use the net proceeds from the offering to conduct ...
The Precise MRD test is Myriad’s tumor-informed circulating tumor DNA (ctDNA) assay designed to support longitudinal monitoring during cancer treatment. Using whole-genome sequencing to create a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results